MiR-5100 promotes tumor growth in lung cancer by targeting Rab6

Cancer Letters

Volumn 362, Issue 1, 2015, Pages 15-24

  Huang, Haili ^a   Jiang, Yun ^a   Wang, Yahong ^a   Chen, Ting ^a   Yang, Lawei ^a   He, Huijuan ^a   Lin, Ziying ^a   Liu, Tie ^b   Yang, Teng ^a   Kamp, David W ^c   Wu, Bin ^a   Liu, Gang ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Cell proliferation; Lung cancer; MiR 5100; Nude mice; Rab6

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 2; GUANOSINE TRIPHOSPHATASE; MICRORNA; MICRORNA 5100; PROTEIN RAB6; UNCLASSIFIED DRUG; MIRN5100 MICRORNA, HUMAN; OLIGONUCLEOTIDE; RAB PROTEIN; RAB6 PROTEIN;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LUNG CANCER; LUNG CANCER CELL LINE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; TUMOR GROWTH; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; GENETIC TRANSFECTION; GENETICS; HEK293 CELL LINE; LUNG TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE; XENOGRAFT;

MUS MUSCULUS;

ANIMALS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; DOWN-REGULATION; FEMALE; G1 PHASE; HEK293 CELLS; HETEROGRAFTS; HUMANS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICRORNAS; OLIGONUCLEOTIDES; RAB GTP-BINDING PROTEINS; S PHASE; TRANSFECTION;

EID: 84931066951     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2015.03.004     Document Type: Article

References (30)

1. Esquela-Kerscher A., Trang P., Wiggins J.F., Patrawala L., Cheng A., Ford L., et al. The let-7 microRNA reduces tumor growth in mouse models of lung cancer. Cell Cycle 2008, 7:759-764.
2. Ren X.S., Yin M.H., Zhang X., Wang Z., Feng S.P., Wang G.X., et al. Tumor-suppressive microRNA-449a induces growth arrest and senescence by targeting E2F3 in human lung cancer cells. Cancer Lett 2014, 344:195-203.
3. Yu T., Li J., Yan M., Liu L., Lin H., Zhao F., et al. MicroRNA-193a-3p and -5p suppress the metastasis of human non-small-cell lung cancer by downregulating the ERBB4/PIK3R3/mTOR/S6K2 signaling pathway. Oncogene 2014, 34:413-423.
4. Lin C.W., Chang Y.L., Chang Y.C., Lin J.C., Chen C.C., Pan S.H., et al. MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1. Nat. Commun 2013, 4:1877.
5. Zhao B., Han H., Chen J., Zhang Z., Li S., Fang F., et al. MicroRNA let-7c inhibits migration and invasion of human non-small cell lung cancer by targeting ITGB3 and MAP4K3. Cancer Lett 2014, 342:43-51.
6. Gu Y., Cheng Y., Song Y., Zhang Z., Deng M., Wang C., et al. MicroRNA-493 suppresses tumor growth, invasion and metastasis of lung cancer by regulating E2F1. PLoS ONE 2014, 9. e102602.
7. Lu Y., Govindan R., Wang L., Liu P.Y., Goodgame B., Wen W., et al. MicroRNA profiling and prediction of recurrence/relapse-free survival in stage I lung cancer. Carcinogenesis 2012, 33:1046-1054.
8. Patnaik S.K., Kannisto E., Knudsen S., Yendamuri S. Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection. Cancer Res 2010, 70:36-45.
9. Gong Z., Yang J., Li J., Yang L., Le Y., Wang S., et al. Novel insights into the role of microRNA in lung cancer resistance to treatment and targeted therapy. Curr. Cancer Drug Targets 2014, 14:241-258.
10. Wu Y., Crawford M., Yu B., Mao Y., Nana-Sinkam S.P., Lee L.J. MicroRNA delivery by cationic lipoplexes for lung cancer therapy. Mol. Pharm 2011, 8:1381-1389.
11. Wang Q.Z., Xu W., Habib N., Xu R. Potential uses of microRNA in lung cancer diagnosis, prognosis, and therapy. Curr. Cancer Drug Targets 2009, 9:572-594.
12. Martinez O., Schmidt A., Salamero J., Hoflack B., Roa M., Goud B. The small GTP-binding protein rab6 functions in intra-Golgi transport. J. Cell Biol 1994, 127:1575-1588.
13. Goud B., Yang C., Roa M., Martinez O., Slepnev V. Study of rab6, a ras-like GTP-binding protein associated with the Golgi complex. Ann. N. Y. Acad. Sci 1994, 733:340-343.
14. Darchen F., Goud B. Multiple aspects of Rab protein action in the secretory pathway: focus on Rab3 and Rab6. Biochimie 2000, 82:375-384.
15. Stedman T.T., Sussmann A.R., Joiner K.A. Toxoplasma gondii Rab6 mediates a retrograde pathway for sorting of constitutively secreted proteins to the Golgi complex. J. Biol. Chem 2003, 278:5433-5443.
16. White J., Johannes L., Mallard F., Girod A., Grill S., Reinsch S., et al. Rab6 coordinates a novel Golgi to ER retrograde transport pathway in live cells. J. Cell Biol 1999, 147:743-760.
17. Iida H., Tanaka S., Shibata Y. Small GTP-binding protein, Rab6, is associated with secretory granules in atrial myocytes. Am. J. Physiol 1997, 272:C1594-C1601.
18. Martinez O., Antony C., Pehau-Arnaudet G., Berger E.G., Salamero J., Goud B. GTP-bound forms of rab6 induce the redistribution of Golgi proteins into the endoplasmic reticulum. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:1828-1833.
19. Storrie B., Micaroni M., Morgan G.P., Jones N., Kamykowski J.A., Wilkins N., et al. Electron tomography reveals Rab6 is essential to the trafficking of trans-Golgi clathrin and COPI-coated vesicles and the maintenance of Golgi cisternal number. Traffic 2012, 13:727-744.
20. Valente C., Polishchuk R., De Matteis M.A. Rab6 and myosin II at the cutting edge of membrane fission. Nat. Cell Biol 2010, 12:635-638.
21. Schlager M.A., Kapitein L.C., Grigoriev I., Burzynski G.M., Wulf P.S., Keijzer N., et al. Pericentrosomal targeting of Rab6 secretory vesicles by Bicaudal-D-related protein 1 (BICDR-1) regulates neuritogenesis. EMBO J. 2010, 29:1637-1651.
22. Indran S.V., Britt W.J. A role for the small GTPase Rab6 in assembly of human cytomegalovirus. J. Virol 2011, 85:5213-5219.
23. Moorhead A.R., Rzomp K.A., Scidmore M.A. The Rab6 effector Bicaudal D1 associates with Chlamydia trachomatis inclusions in a biovar-specific manner. Infect. Immun 2007, 75:781-791.
24. Wang Y.H., Chen J., Lin Z.Y., Cao J., Huang H.L., Jiang Y., et al. Role of deregulated microRNAs in NSCLC progression using FF and FFPE samples. Oncol. Lett 2014.
25. Chen D., Chen Z., Jin Y., Dragas D., Zhang L., Adjei B.S., et al. MicroRNA-99 family members suppress Homeobox A1 expression in epithelial cells. PLoS ONE 2013, 8. e80625.
26. Baldin V., Lukas J., Marcote M.J., Pagano M., Draetta G. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev 1993, 7:812-821.
27. Tsai L.H., Lees E., Faha B., Harlow E., Riabowol K. The cdk2 kinase is required for the G1-to-S transition in mammalian cells. Oncogene 1993, 8:1593-1602.
28. Liu Y., Li M., Zhang G., Pang Z. MicroRNA-10b overexpression promotes non-small cell lung cancer cell proliferation and invasion. Eur. J. Med. Res 2013, 18:41.
29. Kang J., Lee S.Y., Kim Y.J., Park J.Y., Kwon S.J., Na M.J., et al. microRNA-99b acts as a tumor suppressor in non-small cell lung cancer by directly targeting fibroblast growth factor receptor 3. Exp. Ther. Med 2012, 3:149-153.
30. Vermeulen K., Van Bockstaele D.R., Berneman Z.N. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif 2003, 36:131-149.